BAK vs DOW
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
BAK · Braskem$0.74 ▼ 12.61%
DOW · Dow Inc$29.03 ▼ 4.03%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- BAK -75.3%
- DOW +35.1%
Head to head
| Metric | BAK | DOW |
|---|---|---|
| Price | $0.74 | $29.03 |
| Change today | ▼ 12.61% | ▼ 4.03% |
| Market cap | $289.52M | $21.01B |
| Return, 3 months | -59.9% | -6.6% |
| Return, year to date | -75.0% | +28.3% |
| Return, 1 year | -75.1% | +37.1% |
| P/E (TTM) | – | – |
| P/B | -0.1 | 1.3 |
| P/E percentile vs own 5y | 72nd | 2nd |
| Dividend yield | – | 4.82% |
| Revenue growth (YoY, latest qtr) | +21.6% | +13.0% |
| Net profit growth (YoY) | +952.1% | +323.4% |
| Gross margin | 8.9% | 11.1% |
| Operating margin | 6.0% | 5.0% |
| Net margin | -7.8% | -2.1% |
| Return on equity | – | -5.4% |
| Analyst target vs. price | +103.1% | +16.5% |
| Analyst buy share | 0% | 15% |
| RSI (14) | 24 | 36 |
| 30-day volatility | 160.3% | 37.2% |
| Max drawdown, 1 year | -85.3% | -34.8% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Sell | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- DOW is the largest of the group by market value.
- DOW has returned the most over the past year.
- BAK is growing revenue fastest.
- DOW keeps the most profit per dollar of sales.
- DOW has been the calmest stock over the last 30 days.